Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

The Future of The 340B Rebate Pilot No Photo Available

Yeji Jesse Lee

A federal judge halted a new 340B pilot program, handing a win for safety net healthcare providers. Healthcare attorneys say it's too ... (more story)

Drug Pricing Battles To Watch In 2026 No Photo Available

Mark Payne

With drugmakers already pushing back on drug affordability programs and policies, Law360 looks at the year ahead for litigation focuse... (more story)

SnapChat, Pork And Big Prosecutions: Trials To Watch In 2026 No Photo Available

Cara Salvatore

The coming year is set to bring high-profile trials, including in the criminal case against SCOTUSblog co-founder Tom Goldstein, as we... (more story)